Lee CS - Search Results

1

Retrospective clinical study analysis of skin adverse reactions related to epidermal growth factor receptor inhibitors.

Qu JM, Wen SJ, Lin YK, Lu HX, Huang KQ, Maansson CT, Lee CS, Araki T. Qu JM, et al. Among authors: lee cs. Transl Cancer Res. 2024 Jun 30;13(6):3016-3030. doi: 10.21037/tcr-24-486. Epub 2024 Jun 20. Transl Cancer Res. 2024. PMID: 38988913 Free PMC article.

2

A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity.

Lee CS, Sharma S, Miao E, Mensah C, Sullivan K, Seetharamu N. Lee CS, et al. Lung Cancer (Auckl). 2020 Oct 7;11:73-103. doi: 10.2147/LCTT.S258444. eCollection 2020. Lung Cancer (Auckl). 2020. PMID: 33117017 Free PMC article. Review.

3

Safety and Efficacy of Immune Checkpoint Inhibitors in Cancer Patients and Preexisting Autoimmune Disease: A Systematic Review and Meta-Analysis in Non-Small-Cell Lung Cancer.

Aung WY, Lee CS, Morales J, Rahman H, Seetharamu N. Aung WY, et al. Among authors: lee cs. Clin Lung Cancer. 2023 Nov;24(7):598-612. doi: 10.1016/j.cllc.2023.05.006. Epub 2023 May 26. Clin Lung Cancer. 2023. PMID: 37328320

4

Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives.

Fraser M, Seetharamu N, Diamond M, Lee CS. Fraser M, et al. Among authors: lee cs. Cancer Manag Res. 2023 Nov 3;15:1233-1243. doi: 10.2147/CMAR.S386799. eCollection 2023. Cancer Manag Res. 2023. PMID: 37941971 Free PMC article. Review.

5

Penetrating the evidence of EGFR and ALK tyrosine kinase inhibitors for non-small cell lung cancer brain metastases.

Thomas CM, Lee CS. Thomas CM, et al. Among authors: lee cs. J Oncol Pharm Pract. 2019 Apr;25(3):623-637. doi: 10.1177/1078155218796695. Epub 2018 Sep 4. J Oncol Pharm Pract. 2019. PMID: 30176786 Review.

6

Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer.

Miao E, Seetharamu N, Sullivan K, Eng S, Lee CS. Miao E, et al. Among authors: lee cs. J Pharm Pract. 2021 Feb;34(1):11-16. doi: 10.1177/0897190019840596. Epub 2019 Jun 5. J Pharm Pract. 2021. PMID: 31167592

7

Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data.

Lee CS, Milone M, Seetharamu N. Lee CS, et al. Onco Targets Ther. 2021 Aug 26;14:4579-4597. doi: 10.2147/OTT.S227032. eCollection 2021. Onco Targets Ther. 2021. PMID: 34471361 Free PMC article. Review.

8

A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer.

Lee CS, Lam SY, Liu A, Sison C, Zhu XH. Lee CS, et al. Clin Med Insights Oncol. 2023 Feb 1;17:11795549231152073. doi: 10.1177/11795549231152073. eCollection 2023. Clin Med Insights Oncol. 2023. PMID: 36744171 Free PMC article.

9

A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study.

Lee CS, Ahmed I, Miao E, Chung S, Patel K, Kohn N, Seetharamu N. Lee CS, et al. J Oncol Pharm Pract. 2022 Jul;28(5):1140-1151. doi: 10.1177/10781552211020798. Epub 2021 Jun 13. J Oncol Pharm Pract. 2022. PMID: 34120514

10

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.

Wang KY, Newman J, Lee CS, Seetharamu N. Wang KY, et al. Among authors: lee cs. SAGE Open Med. 2021 May 25;9:20503121211017757. doi: 10.1177/20503121211017757. eCollection 2021. SAGE Open Med. 2021. PMID: 34104436 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,550 results

Search Page

Filters